Intaglob 0.165 Injection 2 ml

babies: nil lactating mothers: intaglob should be used with caution during breastfeeding. breastfeeding should be stopped during treatment. pregnancy: intaglob may not be safe to use during pregnancy.
there are limited and inadequate studies on the use of intaglob in pregnant women. take this medicine only if the doctor advises. driving: intaglob affects the ability to drive by causing drowsiness. alcohol: there is not enough evidence of the use of alcohol while taking intaglob injection.
please consult your doctor. kidney: intaglob injection must be used with caution in patients with kidney disease. the dose adjustment is recommended.
seek a doctor’s advice before taking this medicine. liver: intaglob is safe if prescribed in liver disease. the dose adjustment may not be recommended.
seek a doctor’s advice before taking this medicine..

pain, swelling, and redness at the injection site headache rashes drowsiness mild fever chills sore throat diarrhoea abdominal pain.

intaglob works by producing antibodies against the infectious agent and destroying them. this injection is commonly recommended in patients who are at more risk of infection..

consult your doctor immediately if you missed the dose of intaglob injection..

• intaglob injection is most commonly used to provide immunization against hepatitis a, poliomyelitis, and measles. • this injection should be given by a qualified medical practitioner under the skin, i.e., subcutaneously.
• if you experience any undesirable effects, then seek the doctor’s advice. inform your doctor if you have taken any vaccine in the last two months.
• do not drive while taking this injection as it may cause drowsiness. • seek a doctor’s advice before taking this medicine in pregnancy, breastfeeding, liver, and kidney disorder..

monitor closely • intaglob + bcg vaccine live: intaglob decreases effects of live bcg vaccine by opposing its effect. • intaglob + measles mumps and rubella vaccine, live: intaglob decreases effects of live measles mumps and rubella vaccine by opposing its effect. minor • intaglob + phenytoin: mechanism of interaction is unknown. concurrent administration may lead to an increased risk of hypersensitivity myocarditis. • intaglob + ethotoin: mechanism of interaction is unknown.
concurrent administration may lead to an increased risk of hypersensitivity myocarditis..